The research projects are centered on the interface of biomaterials and therapeutics at the nano-micro or macro-scale to prevent, manage or treat diseases using drugs or drug-like compounds or their combinations. The idea is to apply innovative delivery strategies to the existing small or large molecules for improving the risk vs benefit ratio; realize new indications or apply the innovative delivery technologies early on in the drug discovery program to minimize the attrition rates.